Exchange: NASDAQ·Updated 07:59 AM EDT

AMIX News

News
all
press releases
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Autonomix Medical (NASDAQ:AMIX) shares moved upwards by 35.9% to $7.3 during Tuesday's pre-market session. The market value of their outstanding shares is at $5.2 million. Biodexa Pharmaceuticalsread more...
Benzinga
More News
Autonomix Raises $4.9M at Market Premium as Its FDA Push Enters a New Phase
Autonomix Medical (NASDAQ:AMIX) is giving investors a fresh reason to watch the stock closely: the medical-device developer is bringing in another $4.9 million in gross proceeds through the immediate exercise of existing warrants, this time at $5.75 per share, while issuing a new package of warrants exercisable at $6.25.
24-7 Market News
Autonomix Medical (AMIX) Stock Surges 117% After Hours: Here's Why
Autonomix Medical shares surge 117% after hours following a $4.9 million warrant inducement deal.read more...
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Autonomix Medical (NASDAQ:AMIX) stock moved upwards by 142.1% to $13.0 during Monday's after-market session. The company's market cap stands at $5.1 million. Picard Medical (AMEX:PMI) stock rose 34.5%read more...
Benzinga
SpaceX, AMD, Nvidia, Astera Labs and Autonomix Medical: Why These 5 Stocks Are on Investors' Radars Today
Major U.S. stock indexes finished higher on Tuesday, with the Dow Jones Industrial Average climbing 1.71% to 54,085.88.read more...
Benzinga
Autonomix Stock Skyrockets After Obtaining Key Cancer Tech Patent
Autonomix Medical is skyrocketing Tuesday after securing U.S. Patent No. 12,433,670, expanding protection for its nerve-mapping platform.read more...
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Autonomix Medical (NASDAQ:AMIX) stock rose 415.3% to $18.81 during Tuesday's regular session. The company's market cap stands at $1.9 million. Adagio Medical Holdings (NASDAQ:ADGM) shares increased byread more...
Benzinga
Autonomix Extends Rally as Patent Momentum Draws Fresh Attention
Autonomix Medical (NASDAQ:AMIX) continued to build on this morning's momentum following the announcement of a newly issued U.S. patent that expands protection around its precision nerve sensing, mapping and targeted neuromodulation platform. As buying interest accelerated throughout the session, shares began approaching price levels not seen since early 2026, placing the stock back on the radar of momentum traders.
24-7 Market News
Autonomix Expands Its Patent Fortress as Precision Neuromodulation Emerges as a New Frontier in Cancer Care
Autonomix Medical (NASDAQ:AMIX) has strengthened its long-term position in precision medicine with the issuance of U.S. Patent No. 12,433,670, broadening intellectual property protection around its nerve sensing, mapping and targeted neuromodulation platform. While the company remains in the clinical development stage, the new patent reinforces a strategy centered on building a differentiated technology platform that could extend well beyond pain management into oncology, organ-function disorders and diseases of the autonomic nervous system.
24-7 Market News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Autonomix Medical (NASDAQ:AMIX) shares moved upwards by 62.5% to $4.47 during Wednesday's pre-market session. The company's market cap stands at $1.4 million. OneMedNet (NASDAQ:ONMD) shares movedread more...
Benzinga

Advertisement|Remove ads.